Scleroderma Lung Study III - Combining Pirfenidone With Mycophenolate

NCT03221257 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Scleroderma, Systemic
Interstitial Lung Disease

Interventions

DRUG: Pirfenidone (PFD)
DRUG: Placebo (Plac)
DRUG: Mycophenolate Mofetil (MMF)

Sponsor

Michael Roth

Collaborators

[object Object]
[object Object]
[object Object]